Home > Products > Biosimilars

BioSIM anti-Human integrin α4β7/LPAM-1 Antibody (Natalizumab Biosimilar), Research Grade

Catalog: SIM0075
Cost advantage to: SIM0018
Isotype: IgG4-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar antibody uses Natalizumab’s variable regions, ideal for research. It reacts with human VLA-4 (CD49d/integrin α4) — a 150 kDa integrin-family glycoprotein expressed on T/B lymphocytes, monocytes, eosinophils, etc. Integrin α4 binds β7 (forms LPAM-1) and β1 (forms VLA-4), aiding adhesion/T cell co-stimulation; its ligands are VCAM-1, MAdCAM-1, fibronectin.
 

Specifications

Product Name BioSIM anti-Human integrin α4β7/LPAM-1 Antibody (Natalizumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG4-kappa
Target integrin α4β7/LPAM-1
Other Names AN100226, BG00002, CAS: 189261-10-7
CAS 189261-10-7
Reactivity Human
Host Species Humanized
Background This non-therapeutic biosimilar antibody uses Natalizumab’s variable regions, ideal for research. It reacts with human VLA-4 (CD49d/integrin α4) — a 150 kDa integrin-family glycoprotein expressed on T/B lymphocytes, monocytes, eosinophils, etc. Integrin α4 binds β7 (forms LPAM-1) and β1 (forms VLA-4), aiding adhesion/T cell co-stimulation; its ligands are VCAM-1, MAdCAM-1, fibronectin.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products